Sign in Subscribe
Cancer research

Former Sky News Presenter Shares Prostate Cancer Experience

Strategic Insights

— 1 min read

Dermot Murnaghan, a former Sky News presenter, has spoken publicly about his stage four prostate cancer diagnosis, revealing that he "fell through the gaps" with early testing. Despite not having a national screening programme for prostate cancer due to the lack of a reliable test, Murnaghan encouraged men "of a certain age" to "demand" a test on the NHS. He has been undergoing chemotherapy since July and is in the waiting phase to see how his treatment has gone. Murnaghan's experience highlights the importance of proactive testing and awareness for prostate cancer, particularly among men over the age of 50.

Key Takeaways:

  • Dermot Murnaghan, a 67-year-old former Sky News presenter, has revealed that he has stage four prostate cancer and underwent chemotherapy since July.
  • Murnaghan fell through the gaps with early testing and encouraged men "of a certain age" to demand a test on the NHS.
  • The UK does not have a national screening programme for prostate cancer due to the lack of a reliable test.
  • Murnaghan is taking part in Sir Chris Hoy's fundraising charity bike ride, Tour De 4, to raise awareness and funds for cancer charities.
  • NHS guidance highlights that men over the age of 50 are at a higher risk of developing prostate cancer.
  • Murnaghan has presented true crime documentary series Killer Britain and the podcast Legends Of News, and covered big events including the announcement of the death of Queen Elizabeth II.

Statistics:

  • 1 in 8 men will be diagnosed with prostate cancer during their lifetime (Cancer Research UK).
  • The UK does not have a national screening programme for prostate cancer (Cancer Research UK).
  • Prostate cancer is the second most common cancer in men worldwide (World Health Organization).
  • In 2020, there were over 420,000 new cases of prostatic cancer diagnosed worldwide (International Agency for Research on Cancer).
  • A PSA test is a common way to test for prostate cancer, but it can also have false positives and false negatives (National Institute of Diabetes and Digestive and Kidney Diseases).

Sources:

  • Byline: By, Ben Hurst
  • Cancer Research UK
  • World Health Organization
  • International Agency for Research on Cancer
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • NHS Guidance
  • Sky News

Read more